Daniella Yeheskely-Hayon

Directeur Technique/Scientifique/R&D chez QTREX QUANTUM LTD.

Fortune : 8 M $ au 31/05/2026

52 ans

Consumer Services

Health Technology

Technology Services

Profil

Daniella Yeheskely-Hayon is currently the Chief Technology Officer at Inspira Technologies Oxy B.H.N.
Ltd. She previously worked as the Chief Operating Officer & Director-R&D at O2Cure Ltd. She holds a doctorate degree from Technion-Israel Institute of Technology and an MBA from Ono Academic College.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
0,76 %	29/05/2026	243 332 ( 0,76 % )	8 M $	31/05/2026

Postes actifs de Daniella Yeheskely-Hayon

Sociétés	Poste	Début
QTREX QUANTUM LTD.	Directeur Technique/Scientifique/R&D	03/02/2022

Tous les postes actifs de Daniella Yeheskely-Hayon

Anciens postes connus de Daniella Yeheskely-Hayon

Sociétés	Poste	Fin
O2cure Ltd. O2cure Ltd. Information Technology ServicesTechnology Services Operates as an enabling technology for development of long-term blood oxygenators and respiratory assist devices	Directeur des opérations	-

Voir l'expérience en détail de Daniella Yeheskely-Hayon

Formation de Daniella Yeheskely-Hayon

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Daniella Yeheskely-Hayon

Sociétés liées

Entreprise privées	4
Technion-Israel Institute of Technology Technion-Israel Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Ono Academic College Ono Academic College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Inspira Technologies Oxy B.H.N. Ltd. Inspira Technologies Oxy B.H.N. Ltd. Medical SpecialtiesHealth Technology Engages in research, development, manufacture and marketing of proprietary respiratory support technology	Health Technology
O2cure Ltd. O2cure Ltd. Information Technology ServicesTechnology Services Operates as an enabling technology for development of long-term blood oxygenators and respiratory assist devices	Technology Services